Top

Published in:

01-12-2019 | Human Immunodeficiency Virus | Complications of HIV and Antiretroviral Therapy (GA McComsey, Section Editor)

Contemporary Lifestyle Modification Interventions to Improve Metabolic Comorbidities in HIV

Author: Kathleen V. Fitch

Published in: Current HIV/AIDS Reports | Issue 6/2019

Abstract

Purpose of Review

Metabolic comorbidities including diabetes, obesity, dyslipidemia, and hypertension, all of which are traditional cardiovascular disease risk factors that are highly prevalent in people with HIV (PWH). Bone disease including osteopenia, osteoporosis, and fragility fractures is also prevalent in PWH. These comorbidities may be prevented and treated in part with lifestyle modification, including changes to dietary and physical habits. The purpose of this review is to highlight recent literature that characterizes current lifestyle habits in PWH as well as the effectiveness of lifestyle strategies to improve metabolic comorbidities prevalent in PWH.

Recent Findings

Recent studies have expanded our knowledge regarding the current lifestyle habits of PWH as well as the potential for lifestyle modification to prevent or improve comorbidities prevalent in PWH. Clinical trials focusing on lifestyle modification have shown some benefit of such interventions on traditional risk factors for comorbidities; however, significant heterogeneity exists between studies and results are not consistent.

Summary

Further clinical trials are needed including developing lifestyle strategies that are feasible, effective, and sustainable to prevent and decrease prevalence of comorbidities in this population.

Teeraananchai S, Kerr SJ, Amin J, Ruxrungtham K, Law MG. Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis. HIV Med. 2017;18(4):256–66.

Lohse N, Obel N. Update of survival for persons with HIV infection in Denmark. Ann Intern Med. 2016;165(10):749–50.PubMed

Mahy M, Autenrieth CS, Stanecki K, Wynd S. Increasing trends in HIV prevalence among people aged 50 years and older: evidence from estimates and survey data. AIDS. 2014;28(Suppl 4):S453–9.PubMedPubMedCentral

Smit M, Brinkman K, Geerlings S, Smit C, Thyagarajan K, Sighem A, et al. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis. 2015;15(7):810–8.PubMedPubMedCentral

Koethe JR, Jenkins CA, Lau B, Shepherd BE, Justice AC, Tate JP, et al. Rising obesity prevalence and weight gain among adults starting antiretroviral therapy in the United States and Canada. AIDS Res Hum Retrovir. 2016;32(1):50–8.PubMed

Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92(7):2506–12.PubMedPubMedCentral

Freiberg MS, Chang CC, Kuller LH, Skanderson M, Lowy E, Kraemer KL, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;4:1–9.

Rao SG, Galaviz KI, Gay HC, Wei J, Armstrong WS, Del Rio C, et al. Factors associated with excess myocardial infarction risk in HIV-infected adults: a systematic review and meta-analysis. J Acquir Immune Defic Syndr. 2019;81(2):224–30.PubMed

Hoy J, Young B. Do people with HIV infection have a higher risk of fracture compared with those without HIV infection? Curr Opin HIV AIDS. 2016;11(3):301–5.PubMed

10.

Hileman CO, Eckard AR, McComsey GA. Bone loss in HIV: a contemporary review. Curr Opin Endocrinol Diabetes Obes. 2015;22(6):446–51.PubMedPubMedCentral

11.

Llop M, Sifuentes WA, Banon S, Macia-Villa C, Perez-Elias MJ, Rosillo M, et al. Increased prevalence of asymptomatic vertebral fractures in HIV-infected patients over 50 years of age. Arch Osteoporos. 2018;13(1):56.PubMed

12.

Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–50.PubMed

13.

Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.PubMed

14.

Gong Q, Zhang P, Wang J, Ma J, An Y, Chen Y, et al. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing diabetes prevention outcome study. Lancet Diabetes Endocrinol. 2019;7(6):452–61.PubMed

15.

Huovinen V, Ivaska KK, Kiviranta R, Bucci M, Lipponen H, Sandboge S, et al. Bone mineral density is increased after a 16-week resistance training intervention in elderly women with decreased muscle strength. Eur J Endocrinol. 2016;175(6):571–82.PubMed

16.

Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53–8.PubMed

17.

Stone NJ, Robinson J, Lichtenstein AH, Bairey Merz CN, Lloyd-Jones DM, Blum CB, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2013.

18.

National Osteoporosis Foundation. Clinician’s guide to prevention and treatment of osteoporosis. Washington: National Osteoporosis Foundation; 2014.

19.

Aberg JA, Kaplan JE, Libman H, Emmanuel P, Anderson JR, Stone VE, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine association of the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(5):651–81.PubMed

20.

Schwingshackl L, Bogensberger B, Hoffmann G. Diet quality as assessed by the healthy eating index, alternate healthy eating index, dietary approaches to stop hypertension score, and health outcomes: an updated systematic review and meta-analysis of cohort studies. J Acad Nutr Diet. 2018;118(1):74–100 e11.PubMed

21.

de Koning L, Chiuve SE, Fung TT, Willett WC, Rimm EB, Hu FB. Diet-quality scores and the risk of type 2 diabetes in men. Diabetes Care. 2011;34(5):1150–6.PubMedPubMedCentral

22.

Guenther PM, Reedy J, Krebs-Smith SM. Development of the healthy eating index-2005. J Am Diet Assoc. 2008;108(11):1896–901.PubMed

23.

Weiss JJ, Sanchez L, Hubbard J, Lo J, Grinspoon SK, Fitch KV. Diet quality is low and differs by sex in people with HIV. J Nutr. 2019;149(1):78–87.PubMed

24.

Webel AR, Moore SM, Longenecker CT, Currie J, Horvat Davey C, Perazzo J, et al. Randomized controlled trial of the system CHANGE intervention on behaviors related to cardiovascular risk in HIV + adults. J Acquir Immune Defic Syndr. 2018;78(1):23–33.PubMedPubMedCentral

25.

Anema A, Fielden SJ, Shurgold S, Ding E, Messina J, Jones JE, et al. Association between food insecurity and procurement methods among people living with HIV in a high resource setting. PLoS One. 2016;11(8):e0157630.PubMedPubMedCentral

26.

Pieroth R, Rigassio Radler D, Guenther PM, Brewster PJ, Marcus A. The relationship between social support and diet quality in middle-aged and older adults in the United States. J Acad Nutr Diet. 2017;117(8):1272–8.PubMed

27.

Macallan DE, Noble C, Baldwin C, Jebb SA, Prentice AM, Coward WA, et al. Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med. 1995;333:83–8.PubMed

28.

Joy T, Keogh HM, Hadigan C, Lee H, Dolan SE, Fitch K, et al. Dietary fat intake and relationship to serum lipid levels in HIV-infected patients with metabolic abnormalities in the HAART era. AIDS. 2007;21(12):1591–600.PubMedPubMedCentral

29.

Hessol NA, Ameli N, Cohen MH, Urwin S, Weber KM, Tien PC. The association between diet and physical activity on insulin resistance in the women’s interagency HIV study. J Acquir Immune Defic Syndr. 2013;62(1):74–80.PubMedPubMedCentral

30.

Marzel A, Kouyos RD, Reinschmidt S, Balzer K, Garon F, Spitaleri M, et al. Dietary patterns and physical activity correlate with total cholesterol independently of lipid-lowering drugs and antiretroviral therapy in aging people living with human immunodeficiency virus. Open Forum Infect Dis. 2018;5(4):ofy067.PubMedPubMedCentral

31.

Galli L, Rubinacci A, Cocorullo D, Salpietro S, Spagnuolo V, Gianotti N, et al. Optimal dietary calcium intake in HIV treated patients: no femoral osteoporosis but higher cardiovascular risk. Clin Nutr. 2014;33(2):363–6.PubMed

32.

Sales SH, Matta SM, da Silva DC, Assone TA, Fonseca LA, Duarte AJ, et al. High frequency of deficient consumption and low blood levels of 25-hydroxyvitamin D in HIV-1-infected adults from Sao Paulo city. Brazil Sci Rep. 2015;5:12990.PubMed

33.

Li Vecchi V, Soresi M, Giannitrapani L, Mazzola G, La Sala S, Tramuto F, et al. Dairy calcium intake and lifestyle risk factors for bone loss in hiv-infected and uninfected Mediterranean subjects. BMC Infect Dis. 2012;12:192.PubMed

34.

Silveira EA, Santos A, Falco MO, Cardoso RC, Vitorino PVO. Association of physical inactivity with hypertension and low educational level in people living with HIV/AIDS. AIDS Care. 2018;30(8):1004–9.PubMed

35.

Dirajlal-Fargo S, Webel AR, Longenecker CT, Kinley B, Labbato D, Sattar A, et al. The effect of physical activity on cardiometabolic health and inflammation in treated HIV infection. Antivir Ther. 2016;21(3):237–45.PubMed

36.

Global recommendations on physical activity for health. In: Organization WH, editor. Switzerland 2010.

37.

Piercy KL, Troiano RP, Ballard RM, Carlson SA, Fulton JE, Galuska DA, et al. The physical activity guidelines for Americans. JAMA. 2018;320(19):2020–8.PubMed

38.

Vancampfort D, Mugisha J, De Hert M, Probst M, Firth J, Gorczynski P, et al. Global physical activity levels among people living with HIV: a systematic review and meta-analysis. Disabil Rehabil. 2018;40(4):388–97.PubMed

39.

Eckard AR, Jiang Y, Debanne SM, Funderburg NT, McComsey GA. Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy. J Infect Dis. 2014;209(8):1156–64.PubMedPubMedCentral

40.

Perazzo JD, Webel AR, Fichtenbaum CJ, McComsey GA. Bone health in people living with HIV: the role of exercise and directions for future research. J Assoc Nurses AIDS Care. 2018;29(2):330–7.PubMed

41.

Forde C, Loy A, O'Dea S, Mulcahy F, Gormley J, Daly C. Physical activity is associated with metabolic health in men living with HIV. AIDS Behav. 2018;22(6):1965–71.PubMed

42.

Vancampfort D, Mugisha J, Richards J, De Hert M, Probst M, Stubbs B. Physical activity correlates in people living with HIV/AIDS: a systematic review of 45 studies. Disabil Rehabil. 2018;40(14):1618–29.PubMed

43.

Simonik A, Vader K, Ellis D, Kesbian D, Leung P, Jachyra P, et al. Are you ready? Exploring readiness to engage in exercise among people living with HIV and multimorbidity in Toronto, Canada: a qualitative study. BMJ Open. 2016;6(3):e010029.PubMedPubMedCentral

44.

Rehm KE, Konkle-Parker D. Physical activity levels and perceived benefits and barriers to physical activity in HIV-infected women living in the deep south of the United States. AIDS Care. 2016;28(9):1205–10.PubMedPubMedCentral

45.

Henry BL, Quintana E, Moore DJ, Garcia J, Montoya JL. Focus groups inform a mobile health intervention to promote adherence to a Mediterranean diet and engagement in physical activity among people living with HIV. BMC Public Health. 2019;19(1):101.PubMedPubMedCentral

46.

Capili B, Anastasi JK, Chang M, Ogedegbe O. Barriers and facilitators to engagement in lifestyle interventions among individuals with HIV. J Assoc Nurses AIDS Care. 2014;25(5):450–7.PubMedPubMedCentral

47.

Webel AR, Barkley J, Longenecker CT, Mittelsteadt A, Gripshover B, Salata RA. A cross-sectional description of age and gender differences in exercise patterns in adults living with HIV. J Assoc Nurses AIDS Care. 2015;26(2):176–86.PubMed

48.

Ladapo JA, Richards AK, DeWitt CM, Harawa NT, Shoptaw S, Cunningham WE, et al. Disparities in the quality of cardiovascular care between HIV-infected versus HIV-uninfected adults in the United States: a cross-sectional study. J Am Heart Assoc. 2017;6(11):e007107.PubMedPubMedCentral

49.

Levy ME, Greenberg AE, Hart R, Powers Happ L, Hadigan C, Castel A. High burden of metabolic comorbidities in a citywide cohort of HIV outpatients: evolving health care needs of people aging with HIV in Washington. DC HIV Med. 2017;18(10):724–35.PubMed

50.

Davidson N, Sowden D. Evaluation of screening practices for low bone mass and prevalence of osteoporosis and fractures in people living with human immunodeficiency virus attending a sexual health clinic. Intern Med J. 2019;49(9):1119–24.PubMed

51.

Alvarez E, Belloso WH, Boyd MA, Inkaya AC, Hsieh E, Kambugu A, et al. Which HIV patients should be screened for osteoporosis: an international perspective. Curr Opin HIV AIDS. 2016;11(3):268–76.PubMed

52.

Zanetti HR, da Cruz LG, Lourenco CL, Ribeiro GC, de Ferreira Jesus Leite MA, Neves FF, et al. Nonlinear resistance training enhances the lipid profile and reduces inflammation marker in people living with HIV: a randomized clinical trial. J Phys Act Health. 2016;13(7):765–70.PubMed

53.

Bonato M, Galli L, Passeri L, Longo V, Pavei G, Bossolasco S, et al. A pilot study of brisk walking in sedentary combination antiretroviral treatement (cART)-treated patients: benefit on soluble and cell inflammatory markers. BMC Infect Dis. 2017;17(1):61.PubMedPubMedCentral

54.

Cutrono SE, Lewis JE, Perry A, Signorile J, Tiozzo E, Jacobs KA. The effect of a community-based exercise program on inflammation, metabolic risk, and fitness levels among persons living with HIV/AIDS. AIDS Behav. 2016;20(5):1123–31.PubMed

55.

Roos R, Myezwa H, van Aswegen H, Musenge E. Effects of an education and home-based pedometer walking program on ischemic heart disease risk factors in people infected with HIV: a randomized trial. J Acquir Immune Defic Syndr. 2014;67(3):268–76.PubMed

56.

Ezema CI, Onwunali AA, Lamina S, Ezugwu UA, Amaeze AA, Nwankwo MJ. Effect of aerobic exercise training on cardiovascular parameters and CD4 cell count of people living with human immunodeficiency virus/acquired immune deficiency syndrome: a randomized controlled trial. Niger J Clin Pract. 2014;17(5):543–8.PubMed

57.

Balducci S, Zanuso S, Cardelli P, Salvi L, Bazuro A, Pugliese L, et al. Effect of high- versus low-intensity supervised aerobic and resistance training on modifiable cardiovascular risk factors in type 2 diabetes; the Italian diabetes and exercise study (IDES). PLoS One. 2012;7(11):e49297.PubMedPubMedCentral

58.

Reeds DN, Pietka TA, Yarasheski KE, Cade WT, Patterson BW, Okunade A, et al. HIV infection does not prevent the metabolic benefits of diet-induced weight loss in women with obesity. Obesity (Silver Spring). 2017;25(4):682–8.PubMedCentral

59.

Stradling C, Thomas GN, Hemming K, Taheri S, Taylor S, Ross J, et al. The Mediterranean portfolio diet in HIV dyslipidaemia: a randomized controlled trial. Seattle: Conference on Retroviruses and Opportunistic Infections; 2018.

60.

Bloch M, Jayewardene A, Vincent T, Linton N, Quan D, Gowers A. Effectiveness of a team intervention in reducing modifiable cardiovascular disease risk in HIV-infected subjects on antiretroviral therapy. J Int AIDS Soc. 2014;17(4 Suppl 3):19546.PubMedPubMedCentral

61.

Duncan AD, Peters BS, Rivas C, Goff LM Reducing risk of type 2 diabetes in HIV: a mixed-methods investigation of the STOP-diabetes diet and physical activity intervention. Diabetic Med. 2019

62.

Saumoy M, Alonso-Villaverde C, Navarro A, Olmo M, Vila R, Ramon JM, et al. Randomized trial of a multidisciplinary lifestyle intervention in HIV-infected patients with moderate-high cardiovascular risk. Atherosclerosis. 2016;246:301–8.PubMed

63.

Wing RR, Becofsky K, Wing EJ, McCaffery J, Boudreau M, Evans EW, et al. Behavioral and cardiovascular effects of a behavioral weight loss program for people living with HIV. AIDS Behav. 2019.

64.

Santos WR, Paes PP, Ferreira-Silva IA, Santos AP, Vercese N, Machado DR, et al. Impact of strength training on bone mineral density in patients infected with HIV exhibiting lipodystrophy. J Strength Cond Res. 2015;29(12):3466–71.PubMed

65.

Overton ET, Chan ES, Brown TT, Tebas P, McComsey GA, Melbourne KM, et al. Vitamin D and calcium attenuate bone loss with antiretroviral therapy initiation: a randomized trial. Ann Intern Med. 2015;162(12):815–24.PubMedPubMedCentral

66.

Yin MT, RoyChoudhury A, Bucovsky M, Colon I, Ferris DC, Olender S, et al. A randomized placebo-controlled trial of low- versus moderate-dose vitamin D3 supplementation on bone mineral density in postmenopausal women with HIV. J Acquir Immune Defic Syndr. 2019;80(3):342–9.PubMed

67.

Schouten J, Wit FW, Stolte IG, Kootstra NA, van der Valk M, Geerlings SE, et al. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis. 2014;59(12):1787–97.PubMed

68.

Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease. Circulation. 2019;17:CIR0000000000000678.

Title: Contemporary Lifestyle Modification Interventions to Improve Metabolic Comorbidities in HIV
Author: Kathleen V. Fitch
Publication date: 01-12-2019
Publisher: Springer US
Keyword: Human Immunodeficiency Virus
Published in: Current HIV/AIDS Reports / Issue 6/2019
Print ISSN: 1548-3568
Electronic ISSN: 1548-3576
DOI: https://doi.org/10.1007/s11904-019-00467-0

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 6/2019

Contemporary Issues in Pregnancy (and Offspring) in the Current HIV Era

History of the HIV Epidemic in China

Aging with HIV

Evolving HIV Epidemiology in Mainland China: 2009–2018

Growth and Neurodevelopment of HIV-Exposed Uninfected Children: a Conceptual Framework

HIV and Aging in Mainland China: Implications for Control and Prevention Research

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage